Showing results 15 to 19 of 19
< previous
Issue Date | Title | Author(s) |
3-Jun-2024 | Microfluidic Formulation of Diazoxide-Loaded Solid Lipid Nanoparticles as a Novel Approach for Friedreich's Ataxia Treatment | Arduino, I; Santoro, A; De Santis, S; Iacobazzi, RM; Lopedota, AA; Paradies, E; Merla, G; Anjomani Virmouni, S; Palmieri, L; Thomas Marobbio, CM; Denora, N |
2012 | The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model | Ezzatizadeh, V; Pinto, RM; Sandi, C; Sandi, M; Al-Mahdawi, S; Te Riele, H; Pook, MA |
2013 | Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia | Li, L; Voullaire, L; Sandi, C; Pook, MA; Ioannou, PA; Delatycki, MB; Sarsero, JP |
2011 | Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model | Sandi, C; Pinto, RM; Al-Mahdawi, S; Ezzatizadeh, V; Barnes, G; Jones, S; Rusche, JR; Gottesfeld, JM; Pook, MA |
2007 | Somatic instability of the expanded GAA triplet-repeat sequence in Friedreich ataxia progresses throughout life | Pook, M A; De Biase, I; Ramussen, A; Monticelli, A; Al-Mahdawi, S; Cocozza, S; Bidichandani, S |